[68Ga]Ga-NNS309

N/A

Report date: 2025/11/28 15:16:43

NME

Base Information

Drug Name[68Ga]Ga-NNS309

Drug Alias Name[68Ga]Ga-NNS309

ClassificationRadiation-emitting products > Radioactive therapeutic agentSmall molecules > Heterocyclic drugsRadiation-emitting products > Nuclides > Gallium > 68Ga +[4]

Mechanisms of ActionPositron-emission tomography enhancersFibroblast activation protein alpha binders

TargetsProlyl endopeptidase FAP

Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungColorectal NeoplasmsTriple Negative Breast Neoplasms +[5]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryBelgiumCanadaUnited States +[10]

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesNovartis Pharma Ag

China Registration ClassN/A

Develop Information

Active CompaniesNovartis Pharma Ag

Inactive CompaniesN/A

Active IndicationsCarcinoma, Non-Small-Cell LungColorectal NeoplasmsTriple Negative Breast Neoplasms +[5]

Inactive IndicationsN/A

Other Information

ATC CodeN/A